Abaxis third quarter revenues increase 32 percent to $49.8 million Abaxis, Inc priligy 30 mg . , a medical products organization manufacturing point-of-care blood evaluation systems, reported financial outcomes for the third fiscal quarter ended December 31 today, 2012. Record quarterly highlights include: Revenues of $49.8 million, up 32 percent over last year's comparable quarter. North America revenues of $41.8 million, up 31 percent over last year's comparable quarter. Medical market revenues of $9.0 million, up 10 percent over last year's comparable quarter.

Today’s pandemic H1N1 is normally a swine virus, meaning it has recently acquired genetic info from infections that co-infect swine. The statement of jumps of the H1N1 virus from humans into hogs, ferrets, cats and turkeys increases concerns that the H1N1 virus can readily jump to many species. Transmitting of H1N1 virus to hogs provides been reported at a growing frequency. Flu attacks in hogs in European countries, Asia, Australia and North America have already been reported now. Related StoriesEnvironmental factors may lead to development of some childhood cancersCombatting viral and bacterial lung infections with volatile anesthetics: an interview with Dr ChakravarthyResearchers make use of genomic techniques to display why different strains of Salmonella infect particular pet speciesThe Centers for Disease Control and Prevention ( maintains an H1N1 Flu Situation Update in which reviews a widespread pandemic occurring in 48 states.